Amdocs is trading at $38.12, down 38.94% in pre-market after forecasting fiscal 2027 reported revenue to decline 14.3%–17.9%. - The November 3 release showed fiscal 2026 fourth-quarter revenue and adjusted earnings broadly in line with expectations, while also projecting lower earnings. - Amdocs cited T-Mobile-related headwinds, including a recent dispute and reduced discretionary spending. It also announced an eight-year AT&T agreement and the EIS acquisition. - The price move shown is pre-market; volume information was not provided.